Barinthus Biotherapeutics (BRNS) EBITDA (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported EBITDA of -$8.4 million for Q1 2026, up 44.25% on a YoY basis from -$5.8 million in Q1 2025, and up 23.71% quarter-over-quarter from -$11.0 million in Q4 2025.
Barinthus Biotherapeutics (BRNS) EBITDA (2020 - 2026) Analysis & Trends
Barinthus Biotherapeutics has reported EBITDA for 7 years, with the latest figure at -$8.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 44.25% year-over-year to -$8.4 million; the trailing twelve-month figure through Mar 2026 stood at -$49.7 million (up 19.41% YoY), and the FY2025 full-year result was -$56.3 million, up 11.64% from the prior year.
- EBITDA for Q1 2026 stood at -$8.4 million, up from -$11.0 million in the prior quarter.
- The five-year high for EBITDA was $13.2 million in Q2 2022, with the low at -$30.9 million in Q4 2024.
- Historically, EBITDA has averaged -$11.5 million across 5 years, with a median of -$13.6 million in 2023.
- Annual changes were most pronounced in 2022 — EBITDA jumped 230.71% — and 2023, when it slumped 2180.43%.
- Barinthus Biotherapeutics' EBITDA stood at -$25.1 million in 2022, then jumped by 62.5% to -$9.4 million in 2023, then plunged by 228.6% to -$30.9 million in 2024, then soared by 64.54% to -$11.0 million in 2025, then advanced by 23.71% to -$8.4 million in 2026.
- The last three EBITDA figures came in at -$8.4 million (Q1 2026), -$11.0 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -65.83 Mn |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | -8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.37 Mn |
| Dec 31, 2025 | -10.97 Mn |
| Sep 30, 2025 | -17.51 Mn |
| Jun 30, 2025 | -12.83 Mn |
| Mar 31, 2025 | -15.01 Mn |
| Dec 31, 2024 | -30.92 Mn |
| Sep 30, 2024 | 1.06 Mn |
| Jun 30, 2024 | -16.77 Mn |
| Mar 31, 2024 | -17.10 Mn |
| Dec 31, 2023 | -9.41 Mn |
| Sep 30, 2023 | -21.93 Mn |
| Jun 30, 2023 | -18.21 Mn |
| Mar 31, 2023 | -13.61 Mn |
| Dec 31, 2022 | -25.09 Mn |
| Sep 30, 2022 | 7.24 Mn |
| Jun 30, 2022 | 13.24 Mn |
| Mar 31, 2022 | 654,000.00 |
| Dec 31, 2021 | -16.67 Mn |
| Sep 30, 2021 | -5.54 Mn |
| Jun 30, 2021 | -16.85 Mn |